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To examine the effect of multiple surgical treatments on psychological outcomes in women 
with early stage breast cancer (BC) in a prospective follow-up study. Questionnaires for 
depressive symptoms (CES-D), fatigue (FAS), anxiety (STAI-State), physical health 
(WHOQOL-100), psychological health (WHOQOL-100), and overall quality of life and 
general health (WHOQOL-100) were completed before diagnosis (Time-1) and 1 (Time-2), 3 
(Time-3), 6 (Time-4), and 12 (Time-5) months after the last surgical treatment. From the 217 
participating women with early stage BC, 78 (35.9%) needed an additional surgical treatment. 
Using general linear model (repeated measures) psychosocial outcomes over time were 
investigated for the breast conserving therapy and mastectomy group, accounting for type of 
surgery, disease stage, and hormonal therapy. Psychological outcomes did not significantly 
change over time, with the exception of anxiety [Wilks’ Lambda = .72, F(4,86) = 8.55, 
p<.0001, partial eta squared = .29]. On average, women with one and women with two 
surgical treatments did not differ on any outcome measure. No interaction effects were found, 
indicating that changes in outcomes over time were the same for both groups. Women who 
had a repeat surgical treatment did not score differently on psychological outcome measures 
compared with women who were treated ‘efficiently’.  
 
Key terms: breast neoplasm, mastectomy, breast-conserving therapy, reexcisions, second 
surgery 
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Introduction 
Breast cancer (BC) is the most common malignancy in women 
1
 and the most frequent cause 
of death in women aged 35 to 60 years in Europe 
2
. In the Netherlands, one in every nine 
women will develop breast cancer before the age of 85 
3
. The prevalence of BC increases with 
age from 3-4% at age 50-69 to 6% of women older than 70 
4
.  
Surgical treatment is usually the initial treatment for invasive early stage BC. Surgical 
options include breast conserving therapy (i.e., lumpectomy and a sentinel node procedure or 
axillary lymph node dissection followed by radiotherapy; BCT) or mastectomy (i.e., removal 
of the breast and sentinel node procedure or axillary lymph node dissection; MTC). Although 
physicians strive to treat women as effectively as possible, i.e. with a minimum of surgical 
treatments, in practice this is not always possible. For instance, some of the women with early 
stage BC who initially received BCT appear to need additional surgery when the margin of 
tissue around the tumor is not cancer-free. It is estimated that of patients undergoing BCT 30 
to 60% will require a re-excision for residual tissue 
5
. The majority of studies examining the 
effects of surgical treatment in oncology have focused on the effects of type of surgery or 
adjuvant therapy on clinical 
6, 7
 or psychosocial outcomes 
8-14
. In general, no differences are 
found when comparing the long-term survival rate in women with BCT and MTC 
6, 7
. 
However, the incidence of local recurrences is higher in BCT 
7
. Regarding, for instance, 
general quality of life, studies do not report differences between surgical options 
15
. However, 
women with BCT report fewer difficulties with body image than women with MTC 
8, 16
. 
Recently, several studies have focused on determining those clinical factors which may be 
associated with re-excision after BCT 
5, 17-20
. Tumor size 
17, 18, 20




, and the presence of an in situ component 
17, 20
, for instance, have been proposed as risk 
factors for at least one repeat surgical treatment. However, results are rather inconsistent and 
definite conclusions cannot yet be drawn. To the best of our knowledge, it remains unclear 
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whether there is a relationship between the number of surgical treatments women receive after 
BC diagnosis and psychological outcomes. Therefore, the aim of this prospective follow-up 
study was to examine the relationship between second surgery and psychological outcomes 
(i.e., state anxiety, fatigue, depressive symptoms, and aspects of quality of life). We 
hypothesize that both groups will improve over time with regard to the selected psychological 
outcomes, but that women with re-excisions will temporarily have more negative scores. We 
also expect that differences between the groups will not be significant at 12-months after 
surgical treatment.   
 
Methods 
Women with a palpable lump in the breast or an abnormality on a screening mammography 
were referred by their general practitioner to the Department of Surgery of the outpatient 
clinics of the St. Elisabeth Hospital (Tilburg), the Maasland Hospital (Sittard), or the Jeroen 
Bosch Hospital (Den Bosch) in The Netherlands. The present study is part of a larger study 
that focuses on the role of personality on the quality of life in women with early stage BC 
who could choose between breast conserving and ablative surgical treatment. The inclusion of 
patients took place from September 2002 until September 2006.  From the 799 eligible 
women, 609 (76.2%) completed the first set of questionnaires before they visited the surgeon 
or radiologist, i.e. before the diagnosis, benign or malignant, was known (Time-1). In this 
group (N = 609), 225 appeared to have early stage BC; the others had a benign breast problem 
(BBP).  
The main reasons for not participating were the length of questionnaires and the 
amount of stress at the first visit to the hospital.  Women with a history of abnormalities in the 
breast, benign or malignant, or a breast tumor that was too large (>5 centimeter) for BCT, 
were excluded from the study. Participants had to be able to read and write in Dutch.  
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After the baseline measurement before diagnosis (Time-1), the participants were 
divided in two groups: women with early stage breast cancer (BC group) and women with 
benign breast problems (BBP group). Thereafter, women completed questionnaires at 1, 
(Time-2), 3 (Time-3), 6 (Time-4), and 12 (Time-5) months after the last surgical treatment 
(BC). Only the women with a BC diagnosis participated in the present study. The time points 
were chosen in such a way that the follow-up measures would not interfere with the time of 
the treatment modalities. Questionnaires were filled in at home and returned in a stamped 
addressed envelope. Participation in the study was not known to the surgeon in attendance 
and, therefore, could not effect treatment and clinical follow-up. The local ethics committee 
approved the study. All the participants gave written informed consent.  
 
Measures 
Questionnaires assessing socio-demographic factors (marital status, children, paid work, and 
education level) and psychological factors (depressive symptoms, fatigue, state anxiety, 
quality of life) were completed at Time-1. At the other time points women again completed 
questionnaires on psychological factors.  
The Center for Epidemiological Studies- Depression Scale (CES-D) 
21
 is a 20-item 
self-report scale measuring the presence and degree of depressive symptoms over the past 
week. The rating scale ranges from 0 (seldom or never) to 3 ((almost) always). Scores can 
range from 0 to 60. A score of 16 or higher is indicative of experiencing depressive 
symptoms. The CES-D has been established as a valid and reliable measure of depressive 
symptoms in BC patients 
22
. Reliability and criterion validity are good 
23, 24
.  
The Fatigue Assessment Scale (FAS)
25
 is a 10-item questionnaire assessing perceived fatigue 
and exhaustion. The response scale is a 5-point rating scale ranging from 1 (never) to 5 
(always). Scores on the FAS range from 10 to 50. A score of 22 or higher represents being 
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, indicating that patients feel substantially fatigued and that this affects daily life. The 
psychometric properties are good 
26-28
.  
The STAI consists of two 20-item scales for measuring state anxiety and trait anxiety. 
In the present study, only the State Anxiety scale was used. This scale assesses how persons 
feel at a particular moment in time. The STAI State scale has a 4-point rating scale ranging 
from 1 (almost never) to 4 (almost always). A score of 38 or higher represents being anxious. 
The Dutch version of the STAI-State scale has good reliability and validity 
29
.  





, is a cross-culturally developed generic multi-
dimensional quality of life (QOL) measure. This instrument covers 24 specific facets of QOL, 
assessed by 96 questions, and one General Health and Overall Quality of Life facet. In the 
present study, only the Overall Quality of Life and General Health facet, the Physical Health 
domain, and the Psychological Health domain were used. In the general population, the mean 
values of these facets are 13.3 (SD = 0.8), 13.3 (SD = 0.9), 13.9 (SD = 0.5), respectively. A 
high facet score indicates good QOL. Reliability and validity 
31-33
 are adequate and sensitivity 
34
 is high. 
 
Statistical procedure 
Student t-tests and Chi-square tests were used to examine the potential differences between 
participants and non-participants. To examine the influence across time of the number of 
surgical treatments on depressive symptoms, state anxiety, overall quality of life and general 
health, physical health, and psychological health, multivariate analysis of variance 
(MANOVA) with repeated measures were used. Partial eta squared (effect size) was derived 
from the general linear model. An effect size between 0.01 and 0.06 is considered as a small 
effect, while effect sizes between 0.06 and 0.13 and greater than 0.14 are considered as 
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moderate and strong effect sizes, respectively 
35
. Multiple post hoc comparisons were 
corrected with the Bonferroni method. Subsequently, multivariate analysis of covariance 
(MANCOVA) with repeated measures was used, in which type of surgery (BCT/MTC), 
disease stage, and hormone therapy (yes/no) were used as covariates as women with one and 
two surgical treatments differed on these patient characteristics (see Table 1). A p-value < .05 
was considered to be statistically significant. In the text mean scores and standard deviations 
are provided as follows (M ± SD). All statistical analyses were performed using the Statistical 
Package for the Social Sciences (SPSS Chicago, IL, USA; version 14.0). 
 
Results  
At baseline, 225 women completed psychological outcome questionnaires. Figure 1 presents a 
flow chart of this study. Participants did not differ from non-participants with regard to 
sociodemographic (i.e., age, partner status, job status, educational level) and clinical (i.e., 
chemotherapy, radiotherapy, hormone therapy) variables. Eight persons were removed from 
the analyses, because they did not have surgery (n = 4) or had more than two surgical 
treatments (n = 4). From the 217 participating women, 77 (35.5%) needed one repeat surgical 
treatment. Eight persons (10.4%) received a second operation due to complications. Twenty-
two women (28.6%) were converted from BCT to MTC in a second surgery. No differences 
were found between the women who received one or two surgical treatments with regard to 
sociodemographic variables. However, women differed on the clinical characteristics: 
hormone therapy (yes/no), type of surgery (BCT/MTC), and disease stage (stage 0 / I / IIa / 
IIb) (see Table 1). 
. 
* Insert Figure 1 and Table 1 about here * 
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Concerning fatigue, women with one or two surgical treatments did not score 
differently on symptoms of fatigue [F(1,105)=.01, p = .92]. However, an effect for time was 
found (See Table 2). Mean scores of fatigue scores at Time-1 (20.03 ± 7.36) were statistically 
lower than scores at Time-2 (22.95 ± 7.52, p<.0001) and Time-3 (22.94 ± 8.09, p<.0001). In 
addition, mean fatigue scores at Time-5 (20.57 ± 7.11) were significantly lower than mean 
scores at Time-2 (p=.001) and Time-3 (p<.0001). No relationship was found between time 
and number of surgical treatments. After controlling for clinical factors, the effect for time did 
not remain significant [Wilks’ Lambda = .97, F(4,99) = .89, p=.474, partial eta squared = 
.04]. 
Women with one or two surgical treatments did not differ on symptoms of anxiety 
[F(1,92) = .013, p = .91). However, an effect for time was found, indicating a decrease in 
symptoms of anxiety over time (see Figure 2). Mean scores of state anxiety scores at Time-1 
were statistically different from scores at subsequent time points (p<.0001). In addition, 
scores on Time-2 (37.00 ± 11.26) were different from scores on Time-5 (34.38 ± 10.63, p = 
.047). No relationship was found between time and number of surgical treatment. After 
controlling for possible confounders, the effect for time remained significant [Wilks’ Lambda 
= .72, F(4,86) = 8.55, p<.0001, partial eta squared = .29]. 
 
      
* Insert figure 2 about here * 
    
 
Women with one and women with two surgical treatments did not differ on symptoms 
of depressive symptoms [F(1,109)=.14, p=.71, partial eta squared = .001, observed power = 
.07). Concerning depressive symptoms, an effect for time was found, indicating that 
depressive symptoms decrease over time. Mean scores of depressive symptoms at Time-1 
(14.54 ± 9.61) were statistically different from Time-4 (11.68 ± 10.25, p= .02) and Time-5 
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(10.31 ± 8.50, p<.0001). Mean scores at Time-5 were also different from Time-2 (13.08 ± 
9.78, p=.001) and Time-3 (12.63 ± 9.95, p=.003). No interaction effect was found. After 
controlling for possible confounders, the effect for time did not remain significant [Wilks’ 
Lambda =.93, F(4,103) = 1.94, p=.11, partial eta squared =.07]. 
Concerning Overall QOL and General Health, no effect for time was found. No 
interaction effect (time by number of surgical treatments) was found, showing that the number 
of surgical treatments exerted a stable effect on Overall QOL and General Health scores. 
Women with one or two surgical treatments did not differ on symptoms of Overall QOL and 
General Health [F(1,113)=.59, p = .45, partial eta squared = .01, observed power = .12]. 
However, the univariate approach produced different results. Using the Greenhouse-Geiser 
estimates of sphericity (ε = .90), an effect for time was found [F(3.59, 405.18) = 3.23, 
p<.05)]. 
With regard to Physical Health, women with one or two surgical treatments did not 
differ on Physical Health [F(1,113)=.36, p = .55, partial eta squared = .03, observed power = 
.09]. An effect for time was found, indicating that Physical Health increases over time. Mean 
scores of Physical Health scores at Time-5 (14.60 ± 2.51) were statistically different from 
scores at Time-2 (14.04 ± 2.46; p=.006) and Time-4 (14.08 ± 2.42; p=.016). No interaction 
effect (time by number of surgical treatments) was found, showing that the number of surgical 
treatments exerted a stable effect on Physical Health scores. After controlling for possible 
confounders, the effect for time did not remain significant [Wilks’ Lambda = .97, F(4, 107) = 
.72, p=.58, partial eta squared = .03]. 
Women with one or two surgical treatments did not differ on Psychological Health 
[F(1,114)= .98, p = .33, partial eta squared = .01, observed power = .17].  Again an effect for 
time was found, this time indicating that Psychological Health improved over time. Mean 
scores of Psychological Health scores at Time-5 (15.35 ± 2.02) were statistically different 
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from scores at Time-1 (14.81 ± 1.93; p<.05), Time-2 (14.89 ± 2.03; p<.01), and Time-3 
(15.02 ± 2.04; p<.05). No interaction effect (time by number of surgical treatments) was 
found, showing that the number of surgical treatments exerted a stable effect on Psychological 
Health scores. After controlling for possible confounders, the effect for time did not remain 
significant [Wilks’ Lambda = .96, F(4, 108) = .1.21, p = .31, partial eta squared = .04]. 
  
Discussion 
In the Netherlands, there is a fierce debate about the number of re-excisions in women with 
BC. The Inspection for Health Care suggested that, as a rule of thumb, 1 out of  9 women may 
get a second surgical treatment. Besides the costs associated with additional surgery, it is also 
speculated that women who get additional surgery will have, at least initially, more stress 
18
. 
However, no study has documented the effect of the number of surgical treatments on 
psychological outcomes. Does the group of women with more than one surgical treatment 
have more psychological problems than women who received just one operation? Therefore, 
the aim of this prospective follow-up study was to examine potential differences between 
women who received one surgical treatment and women who received two surgical 
treatments. This study showed that, in general, both groups did not differ on psychological 
outcomes, such as depressive symptoms and anxiety, over time. In addition, scores on 
depressive symptoms, anxiety, and fatigue initially decreased over time when we did not 
control for clinical factors. Sukegawa et al. 
36
 have examined anxiety (STAI) in women 
awaiting surgery for suspected ovarian cancer. Before surgery, women scored high on state 
anxiety (50.1 ± 10.7), while these anxiety levels dropped considerably within the two weeks 
after surgical treatment (43.2 ± 11.4). In our study, we also found high anxiety scores before 
diagnosis and the anxiety levels also dropped significantly post-surgery. With regard to 
Overall QOL and General Health, the opposite trend was found. However, when adjuvant 
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therapy and type of surgery were taken into account, these time effects disappeared. The 
effect for time remained present with regard to Physical Health. These findings may seem 
counter-intuitive at first glance. However, several explanations are suggested here. The fact 
that some women in our study needed an additional surgical treatment may not be easy for 
women initially. However, women may also realize that an extra surgery is for their own 
benefit. Irrespective of the number of surgical treatment, the aim is to remove malignant 
tissue from the body. Another explanation may be that the data set is somewhat biased. For 
instance, women with more than an additional surgical treatment tend to drop out more often 
from the study compared with women with one surgery. However, this suggestion was not 
supported by our findings. Both groups did not differ on whether they drop out or the moment 
they dropped out from our study (p>.24).  
Major strength of this study is its longitudinal design. However, this study has several 
limitations. First, women who receive multiple surgical treatments may vary in the type of 
treatment performed. However, as we used a rather small sample, it was not possible to divide 
the sample and examine whether women who received, for instance, BCT twice or women 
who were converted from BCT to MTC differ in psychological functioning. Thus, our 
analyses were performed on a rather heterogeneous group. It would be interesting for future 
studies to further address this issue. Second, this study focused on psychological outcomes 
after surgical treatment. Therefore, no information is present on whether women with a 
repeated surgical treatment score differently on clinical physical outcomes compared with 
women who were operated only once or whether women with a second operation experience 
more often psychiatric disorders (e.g., clinical depression). In order to partly overcome this 
limitation, we have assessed women on the WHOQOL-100-domain Physical health. Based on 
this self-evaluation, no differences were found between women operated once and women 
operated twice. Third, the time points were chosen in such a way that the follow-up measures 
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would not interfere with the time of the treatment modalities. As a consequence, the timing of 
the second measurement point is dependent of the last surgical treatment, which is different in 
both surgical groups. Thus, information on psychological outcomes after the first surgical 
treatment is lacking. However, since, both groups do not differ at one month after surgical 
treatment, we may conclude that potential differences at that point were not long-lasting, 
since no differences were found at all measurement points. Fourth, studies like the current one 
often show relatively high attrition 
37
. Also our study had 71% of the women with early stage 
BC still in the study at one-year after surgical treatment. This might have influenced our 
results. In addition, 191 patients refused to participate. The majority of patients who refused 
to participate had benign breast problems (n = 117; 67% ), while 64 patients (23%) had early 
stage breast cancer. Of these 64 patients, 24 women had a second operation. 
This study shows that before diagnosis, women in both groups are stressed, however, one-
year after surgery most women seem to be recovered psychologically. Clinically, it is 
important to assist those women who have on average more psychological problems than 
others and to monitor those with ongoing problems. 
In conclusion, women with early stage BC receiving multiple surgical treatments do 
not have worse psychological outcomes compared with women with one surgical treatment.   
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Table 1 Patient characteristics 
 Number of operations  
 One 
(N = 141) 
Two 
(N = 78) 
p-value 
Sociodemographic    
Age, years (mean ± SD) 59.3 ±   9.1 57.8 ±   9.5 ns 
Living with a partner (yes/no/missing) 114 / 24 / 3 63 / 12 / 3 ns 
Having children (yes/no/missing) 121 / 18 / 2 65 / 10 / 3 ns 
 Educational level 
 (0-9 yrs/10-14 yrs/ >14 years/missing) 
54 / 60 / 25 / 3 26 / 33 / 13 / 6 ns 
Paid work (yes/no/missing) 50 / 90 / 1 36 / 40 / 2 ns 
Clinical    
Type of surgery (BCT/MTC) 76 / 64 30 / 46 .003 
Conversion from BCT to MTC  22  
Second operation due to complication  8  
Chemotherapy (yes/no) 33 / 108 29 / 49  ns 
Hormone therapy (yes/no) 45 / 96  40 / 38 .003 
Radiotherapy (yes/no) 82 / 59  37 / 41  ns 
Disease stage: 0 / I / IIa / IIb 15 / 71 / 37 /18 9 / 20 / 30 / 17 .021 
Psychological     
Overall QOL and General Health 
(mean ± SD) 
15.5 ±   2.6 16.0 ±   2.3 ns 
Depressive symptoms (mean ± SD) 15.2 ±   9.5 14.1 ±   9.5 ns 
Fatigue (mean ± SD) 20.2 ±   6.9 18.7 ±   6.5 ns 
Anxiety (mean ± SD) 
 
47.8 ± 13.7 47.8 ± 14.2 ns 
Abbreviations: BCT = breast conserving therapy, MTC = mastectomy, SD = standard 
deviation, ns = not significant (p > .05) 
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Table 2. Effects of time for psychological outcomes 
 Wilks’ 
Lambda 












Anxiety .38 F (4, 89) = 36.05  <.0001 .62 
Depressive symptoms .78 F(4,106) =   7.51  <.0001 .22 
Overall QOL and General Health .93 F(4,110) =     .07  .07 .07 
Physical Health .87 F(4,110) =   4.09  .004 .13 
Psychological Health 
 
.88 F(4,110) =   3.49  .01 .11 
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Figure 1. Flow chart of the participants  
 
Figure 2. Mean scores on state anxiety. Women were divided in two groups, according to the 
number of surgical treatments received. Higher scores indicate higher levels of anxiety. 
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